Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales (exclusive of amortization of intangibles) | 241,439 | 248,765 | 475,505 | 444,162 |
| Research and development | 36,321 | 39,954 | 72,831 | 73,016 |
| Selling, general and administrative | 286,823 | 303,622 | 584,598 | 546,421 |
| Amortization of intangibles | 29,560 | 30,189 | 59,086 | 58,991 |
| Acquisition-related costs | 11,080 | 33,156 | 17,457 | 34,213 |
| Restructuring costs | 1,957 | 13,547 | 7,169 | 13,547 |
| Operating income/(loss) | 182,432 | 76,109 | 332,820 | 173,113 |
| Other income/(expense), net |
Item 1. Financial Statements
FAQ
- What is Globus Medical's D&A?
- Globus Medical (GMED) reported D&A of $29.56M in Q2 2026.
- How has Globus Medical's D&A changed year-over-year?
- Globus Medical's D&A decreased by 2.1% year-over-year, from $30.19M to $29.56M.
- What is the long-term trend for Globus Medical's D&A?
- Over 4 years (2021 to 2025), Globus Medical's D&A has grown at a 35.6% compound annual growth rate (CAGR), from $69.87M to $236.4M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Globus Medical's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude